Cargando…

Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022

BACKGROUND: Comparing disease severity between SARS‐CoV‐2 variants among populations with varied vaccination and infection histories can help characterize emerging variants and support healthcare system preparedness. METHODS: We compared COVID‐19 hospitalization risk among New York City residents wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greene, Sharon K., Levin‐Rector, Alison, Kyaw, Nang T. T., Luoma, Elizabeth, Amin, Helly, McGibbon, Emily, Mathes, Robert W., Ahuja, Shama D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835408/ https://www.ncbi.nlm.nih.gov/pubmed/36317297 http://dx.doi.org/10.1111/irv.13062

Ejemplares similares

Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant — New York City, New York, January 1–April 5, 2021
por: Thompson, Corinne N., et al.
Publicado: (2021)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
por: Lambrou, Anastasia S., et al.
Publicado: (2022)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

Notes from the Field: Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 — New York City, November 1, 2022–January 4, 2023
por: Luoma, Elizabeth, et al.
Publicado: (2023)

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
por: Thompson, Mark G., et al.
Publicado: (2022)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

COVID-19 Delta variants—Current status and implications as of August 2021
por: Yu, Flora, et al.
Publicado: (2021)

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
por: Ferdinands, Jill M., et al.
Publicado: (2022)

Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design
por: Greene, Sharon K., et al.
Publicado: (2021)

259. Comparison of the causes of death in patients with delta variant versus omicron variant infections
por: Reum Kim, A, et al.
Publicado: (2022)

GenomeBits insight into omicron and delta variants of coronavirus pathogen
por: Canessa, Enrique, et al.
Publicado: (2022)

Analysis of Factors Influencing the Clinical Severity of Omicron and Delta Variants
por: Zhao, Shanlu, et al.
Publicado: (2023)

Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants
por: Florensa, D., et al.
Publicado: (2022)

COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
por: Taylor, Christopher A., et al.
Publicado: (2022)

Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
por: Duong, Bao V., et al.
Publicado: (2022)

COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles
por: Corriero, Alberto, et al.
Publicado: (2022)

COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar
por: Butt, Adeel A, et al.
Publicado: (2022)

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea
por: Lee, Jin, et al.
Publicado: (2023)

Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
por: Yadav, Pragya D., et al.
Publicado: (2022)

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants
por: Wang, Jianbo, et al.
Publicado: (2022)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2023)

SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants
por: Özüdoğru, Osman, et al.
Publicado: (2022)

A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
por: Ellis, Laura Peyton, et al.
Publicado: (2023)

Negative Predictive Value of the Rapid Test Ag 2019-nCoV During the Predominance of Omicron over the Delta Variant and Implications in the Emergency Department
por: Fyntanidou, Barbara, et al.
Publicado: (2022)

Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022)

Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
por: Relan, Pryanka, et al.
Publicado: (2023)

Managing an evolving pandemic: Cryptic circulation of the Delta variant during the Omicron rise
por: Yaniv, Karin, et al.
Publicado: (2022)

Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant
por: Khan, Khadija, et al.
Publicado: (2022)

The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England
por: Paton, Robert S., et al.
Publicado: (2022)

Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China
por: Li, Kangguo, et al.
Publicado: (2023)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)

The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants
por: Campos, Carolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cjahd3enb5uaj2pqr001ob4m31